- Home
- BLRX vs AMS Comparison
BLRX vs AMS Comparison
Compare BLRX & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- AMS
- Stock Information
- Founded
- BLRX 2003
- AMS 1980
- Country
- BLRX Israel
- AMS United States
- Employees
- BLRX N/A
- AMS N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- AMS Medical Specialities
- Sector
- BLRX Health Care
- AMS Health Care
- Exchange
- BLRX Nasdaq
- AMS Nasdaq
- Market Cap
- BLRX 17.0M
- AMS 17.2M
- IPO Year
- BLRX 2011
- AMS N/A
- Fundamental
- Price
- BLRX $3.67
- AMS $2.52
- Analyst Decision
- BLRX Strong Buy
- AMS
- Analyst Count
- BLRX 2
- AMS 0
- Target Price
- BLRX $19.00
- AMS N/A
- AVG Volume (30 Days)
- BLRX 32.7K
- AMS 4.0K
- Earning Date
- BLRX 08-14-2025
- AMS 08-13-2025
- Dividend Yield
- BLRX N/A
- AMS N/A
- EPS Growth
- BLRX N/A
- AMS N/A
- EPS
- BLRX N/A
- AMS N/A
- Revenue
- BLRX $17,251,000.00
- AMS $29,251,000.00
- Revenue This Year
- BLRX N/A
- AMS $5.06
- Revenue Next Year
- BLRX N/A
- AMS N/A
- P/E Ratio
- BLRX N/A
- AMS N/A
- Revenue Growth
- BLRX 1.19
- AMS 26.61
- 52 Week Low
- BLRX $2.30
- AMS $2.27
- 52 Week High
- BLRX $26.80
- AMS $3.59
- Technical
- Relative Strength Index (RSI)
- BLRX 44.89
- AMS 52.07
- Support Level
- BLRX $3.42
- AMS $2.45
- Resistance Level
- BLRX $3.79
- AMS $2.55
- Average True Range (ATR)
- BLRX 0.25
- AMS 0.06
- MACD
- BLRX 0.02
- AMS 0.01
- Stochastic Oscillator
- BLRX 47.17
- AMS 40.00
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy, and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.